News
Experienced business developer Derek Hicks has been handed the reins of Rezo Therapeutics, his first time at the helm of a ...
Omeros’ efforts to get its transplant drug to market have already suffered one FDA rejection. | Omeros’ efforts to get its ...
Having backed Superluminal Medicines’ series A last year, Eli Lilly has now signed a $1.3 billion pact with the G ...
Evotec’s sweeping reorganization has claimed roughly 600 jobs since last March, 200 more than were originally planned under a ...
Prelude Therapeutics’ lead asset won’t be making it to the second act. | Prelude Therapeutics’ lead asset won’t be making it ...
Shortly after welcoming a new CEO, robot developer Vicarious Surgical reported that it will be delaying the clinical trials ...
Blood oxygen tracking is returning to the Apple Watch after an 18-month hiatus, through a software update effective today. | ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results